Readify

Preservation Against Transmission

Hepatitis C in Renal Disease, Hemodialysis and Transplantation

This flow follows the proposal that pulsatile perfusion can reduce viral burden in HCV-positive donor kidneys.

increasingupBearing stren­gth in each eventdowndecreasing
Cold Storage ProblemCold Storage Problem from "Hepatitis C in Renal Disease, Hemodialysis and Transplantation". Cold Storage Problem Viral burden in the graft Preservation protects renal tissue but may leave viral material associated with the donated kidney.
Cold Storage Problem Viral burden in the graft Preservation protects renal tissue but may leave viral material associated with the donated kidney. The organ can therefore remain a possible source of transmission after implantation. A technical opening If preservation could remove or reduce viral particles, it might complement recipient selection and donor testing. The challenge shifts from virology alone to organ engineering.
Pulsatile PerfusionPulsatile Perfusion from "Hepatitis C in Renal Disease, Hemodialysis and Transplantation". Pulsatile Perfusion Washing the graft Pulsatile perfusion is reported to reduce HCV viral load in procured kidneys.
Pulsatile Perfusion Washing the graft Pulsatile perfusion is reported to reduce HCV viral load in procured kidneys. The technique offers a possible way to lower transmission without discarding the organ. Evidence remains limited The findings are promising but not definitive or consistently reproduced. Technical protection therefore supplements, rather than replaces, recipient screening and consent.
A Layered Safety ModelA Layered Safety Model from "Hepatitis C in Renal Disease, Hemodialysis and Transplantation". A Layered Safety Model Combining safeguards The strongest strategy joins nucleic acid testing, genotype awareness, informed consent, suitable recipient…
A Layered Safety Model Combining safeguards The strongest strategy joins nucleic acid testing, genotype awareness, informed consent, suitable recipient selection, and careful preservation. No single intervention can guarantee nontransmission. From prohibition to management Risk is converted into a set of controllable variables. This layered model permits organ use while preserving transparency about uncertainty.
early donor-organ practice
mid-1990s research period
around 2010